Results 1 to 10 of about 2,790 (200)

Transmasculine pregnancy—Occurrence, associations, and outcomes: A quantitative systematic review [PDF]

Acta Obstetricia et Gynecologica Scandinavica
Introduction Transmasculine people experience incongruence between their gender identity and sex (registered female at birth, AFAB). Little is known about transmasculine pregnancy.
Catherine Meads, Chelsea Daniels, Shawn Walker, Susan Bewley   +3 more
doaj   +3 more sources

Endometriosis in transmasculine individuals

Reproduction and Fertility, 2022
Transmasculine people are assigned female at birth but identify as male. These patients often are prescribed testosterone therapy as part of their transition. This treatment can affect ovulation and stop menstrual periods.
Cecile A Ferrando
doaj   +3 more sources

Non-surgical facial harmonization for gender affirmation and psychosocial well-being in transmasculine persons: an exploratory mixed-methods study [PDF]

São Paulo Medical Journal
BACKGROUND: Facial appearance plays a central role in gender recognition and identity congruence, particularly among transmasculine individuals. Although the demand for gender-affirming care has increased, evidence regarding the psychosocial implications
Liliane Lins-Kusterer, Victor Augusto Bastos e Silva, João Gabriel Macedo Briglia, José Valber Lima Meneses, Larissa do Nascimento Sampaio Celestino, Iza Maura Alves Travenzoli, Rodrigo Fernandes Weyll Pimentel   +6 more
doaj   +3 more sources

Prevalence, demographic factors, co-morbidities, and treatment types associated with acanthosis nigricans in a large cross-section of 900+ transmasculine patients: Data from a single academic center 2016-2023. [PDF]

PLoS ONE
BackgroundAcanthosis nigricans (AN) is a highly visible cutaneous condition that has been associated with cardiometabolic factors, drugs, or malignancy in various populations. AN can be challenging to treat.
Twan Sia, Farah Abou-Taleb, Connie Ma, Shufeng Li, Anne Lynn S Chang   +4 more
doaj   +2 more sources

Impact of testosterone-based gender-affirming hormone therapy on toll-like receptor transcript levels and peripheral blood leukocyte counts in transmasculine individuals [PDF]

Frontiers in Immunology
BackgroundSex differences in immune responses are partly attributed to sex hormones, with testosterone generally associated with dampened immune responses. However, the specific impact of testosterone on the innate immune system in humans remains unclear.
Hüseyin Cihan, Hüseyin Cihan, Hüseyin Cihan, Hüseyin Cihan, Özge Güngör, Gökcen Ünal Kocabas, Esma Pehlivan Köroglu, Kübra Gülpinar, Erhan Pariltay, Ömür Ardeniz, Guy T’Sjoen, Jonatan Leffler, Bettina Winzeler, Bettina Winzeler, Banu Sarer Yürekli   +14 more
doaj   +2 more sources

Patient-reported outcomes following chest masculinization surgery in transmasculine individuals: A prospective study [PDF]

JPRAS Open
Background: Chest masculinization surgery is a cornerstone of gender-affirming care for transmasculine individuals, with well-documented benefits on body image and quality of life.
Yannick Sprunger, Kevin Serror, Raffaele Aguglia, Guillaume Mulier, Olivier Mathieu, Jad Bissar, Marc Chaouat, David Boccara   +7 more
doaj   +2 more sources

Normative evolution and institutional challenges of reproductive health of trans men and transmasculine people in Brazil: a scoping review [PDF]

Cadernos de Saúde Pública
This study aimed to map and analyze the normative evolution and institutional challenges related to the reproductive health of trans men and transmasculine people in Brazil.
Nicole Delgado Austregésilo, Danielle Boachá Sampaio, Marina Sales Afonso de Melo, Vitória Camila Lima Mello de Moraes Marques, Eduarda Correia Moretti, Caroline Wanderley Souto Ferreira, Leila Maria Alvares Barbosa   +6 more
doaj   +3 more sources

Prevalence and Incidence of Heart Failure Phenotypes Among Transgender and Gender‐Diverse Adults in the United States [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Prevalent and incident heart failure (HF) and its comorbidities have not been characterized in transgender and gender‐diverse (TGD) populations. This study determines the prevalence and incidence of HF phenotypes by gender identity.
Ian K. Everitt, Emily K. Quinn, Meredith S. Duncan, Chris Grasso, Sari L. Reisner, Guneet K. Jasuja, Tonia Poteat, Ayelet Shapira‐Daniels, Howard Cabral, Vin Tangpricha, Michael K. Paasche‐Orlow, Emelia J. Benjamin, Monica Mukherjee, Carl G. Streed   +13 more
doaj   +2 more sources

Nationwide estimates of all-cause and cause-specific mortality among individuals with gender dysphoria in Sweden, 2001–2023: a register-based cohort studyResearch in context [PDF]

EClinicalMedicine
Summary: Background: Transgender and gender-diverse (TGD) people experience elevated mortality risk, yet population-based estimates of cause-specific mortality remain limited.
Kristen D. Clark, Richard A. White, Sarah S. Jackson, Alkistis Skalkidou, Thomas Frisell, Fotios C. Papadopoulos   +5 more
doaj   +2 more sources

Initial Psychometric Evaluation of a Brief Sexual Functioning Screening Tool for Transmasculine Adults: Transmasculine Sexual Functioning Index [PDF]

Sexual Medicine, 2020
Introduction: Evaluation of sexual functioning in transmasculine (TM) adults—those who identify as men, male, transmen, or non-binary yet were assigned a female sex at birth—is limited by lack of availability of brief screening measures.
Sari L. Reisner, ScD, David R. Pletta, MPH, Jennifer Potter, MD, Madeline B. Deutsch, MD, MPH   +3 more
doaj   +3 more sources